The design and development of drugs acting against the smallpox virus.
The eradication of smallpox was announced by the WHO in 1980. However, smallpox has not totally disappeared from people's minds because of its potential use as a biological weapon. Further outbreaks of smallpox would, needless to say, be devastating in a population, which has little or no immun...
Main Authors: | El Omari, K, Stammers, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Smallpox Control Act- 2020 B.S. (1964)
by: No Author
Published: (2003-01-01) -
Optimization of Vaccine Virus Accumulation in the Development of Smallpox Drugs Based on Cell Cultures
by: A. V. Ovchinnikov, et al.
Published: (2019-04-01) -
Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design
by: El Omari, K, et al.
Published: (2006) -
Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design.
by: El Omari, K, et al.
Published: (2006) -
Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
by: El Omari, K, et al.
Published: (2006)